Mednet Logo
HomeQuestion

How do you manage a patient with decreased but residual PET activity following concurrent chemoRT and PCI for limited stage SCLC?

5
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Indiana Univ Simon Cancer Center

I agree with @Dr. First Last. There are too many false positive PET scans in the mediastinum. There is no effective second line therapy. Only under the rarest of situations would we consider biopsy to prove this is persistent SCLC and consider surgical resection. The best advice I could give would b...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Radiation Oncology · Quillen VA Medical Center

I think I was the last to know that PET was OK in initial staging, and I will be the last to think PET is worth the price in re-stage. Until we find curative salvage for SCLC, early detection of recurrence or residual is not worth the price. And applying a “treat oligometastasis” argument does not h...

Register or Sign In to see full answer